Global crypto funds break 2021 inflow record in under 3 months in 2024
Crypto investment products have smashed the yearly inflow record after just three months of trading in 2024, adding more than $12 billion globally, according to CoinShares.Inflows of nearly $1.8 billion this week alone were enough to break the prior record of $10.6 billion for all of 2021 — dominated by the success of the new U.S. spot bitcoin ETFs.
This week's inflows of $1.76 billion into global crypto exchange-traded funds and exchange-traded products were enough to break the record — dominated by substantial inflows generated by the new spot bitcoin ETFs in the United States.
“Digital Assets ETFs/ETPs have smashed the 2021 record, with inflows following the last few days now sitting at $12 billion year-to-date compared to $10.6 billion for the whole of 2021,” CoinShares Head of Research James Butterfill wrote .
Global crypto investment products witnessed record inflows last week, adding nearly $2.7 billion, and had already reached the $10.3 billion mark in 2024 before this week began.
Weekly crypto asset flows. Images: CoinShares .
The crypto funds also generated a new record trading volume of $43 billion last week — nearly 50% higher than the prior peak of $30 billion set just the week before. Combined with recent price gains in the crypto market, total assets under management at the funds have also reached record highs nearing $100 billion.
So far, crypto investment products based on exchanges in the United States have unsurprisingly dominated this week, effectively generating 100% of the inflows as fund flows in other countries canceled themselves out.
RELATED INDICES
Flows by exchange country. Image: CoinShares .
U.S. spot bitcoin ETFs have brought in more than 88% or $1.55 billion of the inflows this week alone — including a record daily net inflow of $1 billion on Tuesday, mainly consisting of BlackRock’s IBIT ETF. That product registered a $849 million daily inflow record of its own Tuesday, and its assets under management crossed $15 billion for the first time.
The bitcoin price set fresh all-time highs earlier today, rising to a peak of $73,710 before correctly, according to The Block’s price page .
Earlier this week, CoinShares completed its acquisition of Valkyrie Funds — including its BRRR spot bitcoin ETF — enabling the European asset manager to expand into the U.S. market.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
